Summit Securities Group’s Dentsply Sirona XRAY Stock Holding History

Summit Securities Group’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.5K	Buy	1,276 +103	+9%	+$1.13K	﹤0.01%	794
2026 Q1	$13.6K	Buy	+1,173	New	+$14.6K	﹤0.01%	606
2023 Q3	–	Sell	-278	Closed	-$11K	–	1074
2023 Q2	$11K	Sell	278 -143	-34%	-$5.69K	﹤0.01%	771
2023 Q1	$17K	Buy	421 +204	+94%	+$7.49K	﹤0.01%	651
2022 Q4	$7K	Sell	217 -95	-30%	-$2.86K	﹤0.01%	1067
2022 Q3	$9K	Sell	312 -137	-31%	-$4.68K	﹤0.01%	802
2022 Q2	$16K	Buy	449 +359	+399%	+$14.5K	﹤0.01%	798
2022 Q1	$4K	Buy	+90	New	+$4.76K	﹤0.01%	1010
2017 Q3	–	Sell	-3,188	Closed	-$207K	–	316
2017 Q2	$207K	Sell	3,188 -3,646	-53%	-$230K	0.04%	204
2017 Q1	$427K	Buy	6,834 +549	+9%	+$33K	0.12%	181
2016 Q4	$363K	Buy	+6,285	New	+$371K	0.08%	173

Other funds holding XRAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Summit Securities Group's XRAY Position: Q2 2026 in Review

Summit Securities Group increased its Dentsply Sirona (XRAY) stake by 8.8% in Q2 2026, buying an estimated $1.13K and bringing the position to 1,276 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #794.

Summit Securities Group first reported a position in XRAY in Q4 2016 and has held it in 11 quarters since. The position peaked at $427K in Q1 2017. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

Summit Securities Group held 1,276 shares of Dentsply Sirona worth $13.5K as of Q2 2026.
Summit Securities Group bought 103 Dentsply Sirona shares in Q2 2026, an estimated $1.13K.
Dentsply Sirona made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #794 holding.
Summit Securities Group first reported a position in Dentsply Sirona in Q4 2016 and has held it in 11 quarters since.
Summit Securities Group's Dentsply Sirona position peaked at $427K in Q1 2017.
374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.